InnovHeart s.r.l develops Transcatheter Mitral Valve Replacement systems (TMVR) to treat patients suffering from mitral valve disease. The Company is in late preclinical development of its novel TMVR Saturn Prosthesis, designed to be consistent with the anatomy of the mitral valve and, currently, in development as a Transapical as well as a Transeptal system.
Health Care, Medical
Between €10 million-€25 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as InnovHeart? We’re happy to assist you with our Startup Sourcing service.